If you need more lookups,
subscriptions start at $34 USD/month.
Elisabeth Kogan Location
Israel
Elisabeth Kogan Work
CEO and Co-founder at Syremis Therapeutics @ (December 2025 - Present)
Board Member @ (December 2021 - Present)
CEO and Co-founder at Clexio Biosciences @ Clexio Biosciences (March 2018 - Present)
SVP InnoTech (Innovation and Technologies) @ (January 2016 - April 2018)
SVP Global Generic R and D @ (July 2010 - December 2015)
VP Global Portfolio Strategy @ (January 2009 - October 2010)
Board Member @ (January 2013 - January 2018)
VP Sales and Marketing - TAPI @ (January 2002 - January 2008)
Process Development @ (January 1996 - January 1996)
Elisabeth Kogan Education
CentraleSupélec
Master of Science - MS (Sciences and Engineering)
1993-1996
classes preparatoires Chaptal
mathematics (physics, chemistry)
1991-1993
Elisabeth Kogan Skills
R&D
Pharmaceutical Industry
Technology Transfer
Biotechnology
Life Sciences
Medical Devices
Regulatory Affairs
Biopharmaceuticals
Drug Development
Product Launch
Clinical Development
Oncology
Commercialization
Start-ups
Clinical Trials
Drug Discovery
Strategy
Pharmaceutics
Business Development
Business Strategy
CRO
FDA
Generic Programming
Healthcare
Licensing
Lifesciences
Market Analysis
Marketing Strategy
Product Development
Research and Development (R&D)
Start-up
Start Ups
Research and Development R&d
Management
Microsoft Excel
JavaScript
Engineering
Research and Development
Elisabeth Kogan Summary
Elisabeth Kogan, based in Israel, is currently a CEO and Co-founder at Syremis Therapeutics at Syremis Therapeutics. Elisabeth Kogan brings experience from previous roles at Medincell, Clexio Biosciences and Teva Pharmaceuticals. Elisabeth Kogan holds a 1993 - 1996 Master of Science - MS in Sciences and Engineering @ CentraleSupélec. With a robust skill set that includes R&D, Pharmaceutical Industry, Technology Transfer, Biotechnology, Life Sciences and more. Elisabeth Kogan has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Elisabeth Kogan?
Find contact details for 700 million professionals.